| Q54382849 | Association between epidermal growth factor receptor gene copy number and ERCC1, BRCA1 protein expression in Chinese patients with non-small cell lung cancer. |
| Q41862336 | Association of epidermal growth factor receptor and K-Ras mutations with smoking history in non-small cell lung cancer patients |
| Q54441930 | EGFR and TTF-1 gene amplification in surgically resected lung adenocarcinomas: clinicopathologic significance and effect on response to EGFR-tyrosine kinase inhibitors in recurred cases. |
| Q53249127 | EGFR gene copy number gain is related to high tumor SUV and frequent relapse after adjuvant chemotherapy in resected lung adenocarcinoma. |
| Q37132684 | Molecular epidemiology of female lung cancer |
| Q36385082 | Polymorphisms in intron 1 of the EGFR gene in non-small cell lung cancer patients |
| Q35076206 | Predictive and prognostic markers for epidermal growth factor receptor inhibitor therapy in non-small cell lung cancer |
| Q33697964 | Prognostic factors in resected lung carcinomas |
| Q27692669 | Prognostic value of epidermal growth factor receptor mutations in resected non-small cell lung cancer: a systematic review with meta-analysis |
| Q33634703 | Relationship between EGFR expression, copy number and mutation in lung adenocarcinomas |
| Q42949613 | The predictive value of EGFR status in non-small cell lung cancer patients treated with EGFR-TKIs |
| Q40570622 | Treatments and outcomes of advanced/recurrent non-small cell lung cancer harboring the EGFR T790M mutation: a retrospective observational study of 141 patients in Japan |
| Q48096086 | Ubiquitin-specific protease 8 is a novel prognostic marker in early-stage lung adenocarcinoma. |
| Q55465380 | [Predictive role of EGFR mutation status on postoperative prognosis in patients with resected lung adenocarcinomas]. |